Immunological considerations of modern animal models of malignant primary brain tumors

Citations of this article
Mendeley users who have this article in their library.

This article is free to access.


Recent advances in animal models of glioma have facilitated a better understanding of biological mechanisms underlying gliomagenesis and glioma progression. The limitations of existing therapy, including surgery, chemotherapy, and radiotherapy, have prompted numerous investigators to search for new therapeutic approaches to improve quantity and quality of survival from these aggressive lesions. One of these approaches involves triggering a tumor specific immune response. However, a difficulty in this approach is the the scarcity of animal models of primary CNS neoplasms which faithfully recapitulate these tumors and their interaction with the host's immune system. In this article, we review the existing methods utilized to date for modeling gliomas in rodents, with a focus on the known as well as potential immunological aspects of these models. As this review demonstrates, many of these models have inherent immune system limitations, and the impact of these limitations on studies on the influence of pre-clinical therapeutics testing warrants further attention. © 2009 Sughrue et al; licensee BioMed Central Ltd.




Sughrue, M. E., Yang, I., Kane, A. J., Rutkowski, M. J., Fang, S., James, C. D., & Parsa, A. T. (2009, October 8). Immunological considerations of modern animal models of malignant primary brain tumors. Journal of Translational Medicine.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free